ZERO CANDIDA TECHNOLOGIES INC fell 21.4% on Monday, November 9, 2026, on 1,000 shares. No headline about ZCT came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
ZERO CANDIDA TECHNOLOGIES INC (ZCT:TSXV) closed at $0.105 on November 12, 2026, down 4.55% on the day. It is trading at its 52-week low of $0.105. Over the past year, it lost 60.4%. ZERO CANDIDA TECHNOLOGIES INC is part of the Miscellaneous sector.
In 252 trading sessions since November 12, 2025, ZCT closed higher on 17 days (7%). Its best day was November 2, 2026 (+27.27%) and its worst was October 6, 2026 (-21.43%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 12 times.
Zero Candida is focused on commercial exploitation of a number of patents and patent applications with respect to an AI smart tampon-like device, designed to treat Candidiasis and transfer the medical information via Wi-Fi to the doctor. ZC technology is a combination of a therapy light source with a selected wavelength and intensity and a transparent gel-based drug delivery system to maintain the optimum Ph level in the vagina. The device when used overnight, demonstrated a 99.9999% Candidiasis elimination in the vagina within 3 nights. ZC developed a first prototype of its device in May of 2022 and immediately commenced its first laboratory tests as a "proof of concept". In September 2023 ZC completed its pre-clinical animal studies and subsequently developed a protype (1st series) and commenced its validation. ZC is currently in the process of developing the design of its device and continues pre-clinical animal studies.
Find more stocks like ZCT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.